Myeloproliferative neoplasm CT: Difference between revisions

Jump to navigation Jump to search
No edit summary
No edit summary
Line 15: Line 15:
}}</ref>
}}</ref>
==CT==
==CT==
Abdominal and chest CT scan may be helpful in the diagnosis of myeloproliferative neoplasm. Findings on CT scan suggestive of myeloproliferative neoplasm include enlarged lymph nodes, [[splenomegaly]], and splanchnic venous thrombosis.<ref name="cancer.ca">Canadian Cancer Society.2015.http://www.cancer.ca/en/cancer-information/cancer-type/leukemia-chronic-myelogenous-cml/diagnosis/?region=ab</ref><ref>{{Cite journal
Abdominal and chest CT scan may be helpful in the diagnosis of myeloproliferative neoplasm. Findings on CT scan suggestive of myeloproliferative neoplasm include:<ref name="cancer.ca">Canadian Cancer Society.2015.http://www.cancer.ca/en/cancer-information/cancer-type/leukemia-chronic-myelogenous-cml/diagnosis/?region=ab</ref><ref>{{Cite journal
  | author = [[R. A. Bird]], [[M. G. Low]] & [[J. Stephen]]
  | author = [[R. A. Bird]], [[M. G. Low]] & [[J. Stephen]]
  | title = Immunopurification of phospholipase C (alpha-toxin) from Clostridium perfringens
  | title = Immunopurification of phospholipase C (alpha-toxin) from Clostridium perfringens
Line 26: Line 26:
  | pmid = 4370089
  | pmid = 4370089
}}</ref>
}}</ref>
*Enlarged lymph nodes
*[[Splenomegaly]]
*Splanchnic venous thrombosis
==References==
==References==
{{Reflist|2}}
{{Reflist|2}}

Revision as of 15:13, 26 October 2015

Myeloproliferative Neoplasm Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating myeloproliferative neoplasm from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications, and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X-ray

Echocardiography and Ultrasound

CT scan

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Myeloproliferative neoplasm CT On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Myeloproliferative neoplasm CT

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Myeloproliferative neoplasm CT

on Myeloproliferative neoplasm CT

Myeloproliferative neoplasm CT in the news

Blogs on Myeloproliferative neoplasm CT

Directions to Hospitals Treating Myeloproliferative neoplasm

Risk calculators and risk factors for Myeloproliferative neoplasm CT

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Mohamad Alkateb, MBBCh [2]

Overview

Abdominal and chest CT scan may be helpful in the diagnosis of myeloproliferative neoplasm. Findings on CT scan suggestive of myeloproliferative neoplasm include enlarged lymph nodes, splenomegaly, and splanchnic venous thrombosis.[1][2]

CT

Abdominal and chest CT scan may be helpful in the diagnosis of myeloproliferative neoplasm. Findings on CT scan suggestive of myeloproliferative neoplasm include:[1][3]

  • Enlarged lymph nodes
  • Splenomegaly
  • Splanchnic venous thrombosis

References

  1. 1.0 1.1 Canadian Cancer Society.2015.http://www.cancer.ca/en/cancer-information/cancer-type/leukemia-chronic-myelogenous-cml/diagnosis/?region=ab
  2. R. A. Bird, M. G. Low & J. Stephen (1974). "Immunopurification of phospholipase C (alpha-toxin) from Clostridium perfringens". FEBS letters. 44 (3): 279–281. PMID 4370089. Unknown parameter |month= ignored (help)
  3. R. A. Bird, M. G. Low & J. Stephen (1974). "Immunopurification of phospholipase C (alpha-toxin) from Clostridium perfringens". FEBS letters. 44 (3): 279–281. PMID 4370089. Unknown parameter |month= ignored (help)

Template:WH Template:WS